A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events
Clinical trial NCT07712380 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07712380
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2029-05-04
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.